Document Detail

The Effect of Radiation Timing on Patients With High-Risk Features of Parameningeal Rhabdomyosarcoma: An Analysis of IRS-IV and D9803.
MedLine Citation:
PMID:  24074925     Owner:  NLM     Status:  In-Data-Review    
PURPOSE: Radiation therapy remains an essential treatment for patients with parameningeal rhabdomyosarcoma (PMRMS), and early radiation therapy may improve local control for patients with intracranial extension (ICE).
METHODS AND MATERIALS: To address the role of radiation therapy timing in PMRMS in the current era, we reviewed the outcome from 2 recent clinical trials for intermediate-risk RMS: Intergroup Rhabdomyosarcoma Study (IRS)-IV and Children's Oncology Group (COG) D9803. The PMRMS patients on IRS-IV with any high-risk features (cranial nerve palsy [CNP], cranial base bony erosion [CBBE], or ICE) were treated immediately at day 0, and PMRMS patients without any of these 3 features received week 6-9 radiation therapy. The D9803 PMRMS patients with ICE received day 0 X-Ray Therapy (XRT) as well; however, those with either CNP or CBBE had XRT at week 12.
RESULTS: Compared with the 198 PMRMS patients from IRS-IV, the 192 PMRMS patients from D9803 had no difference (P<.05) in 5-year local failure (19% vs 19%), failure-free-survival (70% vs 67%), or overall survival (75% vs 73%) in aggregate. The 5-year local failure rates by subset did not differ when patients were classified as having no risk features (None, 15% vs 19%, P=.25), cranial nerve palsy/cranial base of skull erosion (CNP/CBBE, 15% vs 28%, P=.22), or intracranial extension (ICE, 21% vs 15%, P=.27). The D9083 patients were more likely to have received initial staging by magnetic resonance imaging (71% vs 53%).
CONCLUSIONS: These data support that a delay in radiation therapy for high-risk PMRMS features of CNP/CBBE does not compromise clinical outcomes.
Aaron C Spalding; Douglas S Hawkins; Sarah S Donaldson; James R Anderson; Elizabeth Lyden; Fran Laurie; Suzanne L Wolden; Carola A S Arndt; Jeff M Michalski
Related Documents :
8416885 - Hyperthermia and radiation in advanced malignant melanoma.
8453705 - Preoperative systemic etoposide/ifosfamide/doxorubicin chemotherapy combined with regio...
6511525 - Temperature elevation during brachytherapy for carcinoma of the uterine cervix: adverse...
14567025 - Rationale for hyperthermia with intraoperative intraperitoneal chemotherapy agents.
6287875 - Hepatopathy following irradiation and chemotherapy for wilms' tumor.
22089465 - Rituximab maintenance therapy for granulomatosis with polyangiitis and microscopic poly...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of radiation oncology, biology, physics     Volume:  87     ISSN:  1879-355X     ISO Abbreviation:  Int. J. Radiat. Oncol. Biol. Phys.     Publication Date:  2013 Nov 
Date Detail:
Created Date:  2013-09-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7603616     Medline TA:  Int J Radiat Oncol Biol Phys     Country:  United States    
Other Details:
Languages:  eng     Pagination:  512-6     Citation Subset:  IM    
Copyright Information:
Copyright © 2013 Elsevier Inc. All rights reserved.
Kosair Children's Hospital and Brain Tumor Center, Louisville, Kentucky. Electronic address:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation ther...
Next Document:  Long-term Evaluation of Radiation-Induced Optic Neuropathy After Single-Fraction Stereotactic Radios...